Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866435 · ClinicalTrials.gov registry record · Early Phase 1
Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
A Early Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 27
- Enrollment target
NCT02866435 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 27 participants.
The verdict
NCT02866435, a Early Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how the brain responds to low blood glucose in non-diabetic individuals. The ultimate goal is to understand the brain substrates of hypoglycemia unawareness, a condition that can occur in patients with type1 diabetes undergoing insulin treatment.In the present study, the investigators focus on differences between two groups of non-diabetic subjects: one group who experienced two episodes of hypoglycemia the day prior to the study (and supposedly developed some level of unawareness to hypoglycemia), and one group who did not. In this study, a 3 tesla MRI scanner is used to acquire brain images. The imaging system is identical to the ones used in hospitals.
Interventions
- DRUG Insulin
- DRUG Glucose
- DRUG Potassium phosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-12-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02866435
The ClinicalTrials.gov registry entry for NCT02866435 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Insulin is the first listed.
NCT02866435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02866435 about?
NCT02866435 is a clinical study titled "Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes". The purpose of this study is to investigate how the brain responds to low blood glucose in non-diabetic individuals. The ultimate goal is to understand the brain substrates of hypoglycemia unawareness, a condition that can occur in patients with type1 diabetes undergoing insulin treatment.In the pre...
What is the current status of trial NCT02866435?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 27 participants. The study started on 2016-11. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT02866435?
The interventions under investigation include: Insulin (DRUG), Glucose (DRUG), Potassium phosphate (DRUG).
Who is sponsoring clinical trial NCT02866435?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.